Viewing Study NCT01015027


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2025-12-26 @ 4:11 AM
Study NCT ID: NCT01015027
Status: COMPLETED
Last Update Posted: 2013-06-17
First Post: 2009-11-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Ascending Dose Study of the Safety and Tolerability of REGN668(SAR231893) in Normal Healthy Volunteers
Sponsor: Regeneron Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-10
Start Date Type: None
Primary Completion Date: 2010-07
Primary Completion Date Type: ACTUAL
Completion Date: 2010-07
Completion Date Type: ACTUAL
First Submit Date: 2009-11-10
First Submit QC Date: None
Study First Post Date: 2009-11-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-06-13
Last Update Post Date: 2013-06-17
Last Update Post Date Type: ESTIMATED